A detailed history of Covestor LTD transactions in Vericel Corp stock. As of the latest transaction made, Covestor LTD holds 23 shares of VCEL stock, worth $1,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 22 4.55%
Holding current value
$1,311
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$42.25 - $53.56 $42 - $53
1 Added 4.55%
23 $1,000
Q2 2024

Aug 09, 2024

BUY
$41.71 - $52.9 $83 - $105
2 Added 10.0%
22 $1,000
Q1 2024

May 10, 2024

BUY
$32.52 - $52.33 $357 - $575
11 Added 122.22%
20 $1,000
Q4 2023

Feb 09, 2024

BUY
$30.85 - $37.09 $154 - $185
5 Added 125.0%
9 $0
Q4 2022

Feb 13, 2023

SELL
$17.65 - $27.37 $17 - $27
-1 Reduced 20.0%
4 $0
Q2 2022

Aug 10, 2022

SELL
$22.88 - $39.45 $45 - $78
-2 Reduced 28.57%
5 $0
Q1 2022

May 13, 2022

SELL
$31.69 - $43.29 $221 - $303
-7 Reduced 50.0%
7 $0
Q4 2021

Feb 10, 2022

BUY
$35.2 - $52.6 $492 - $736
14 New
14 $1,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.69B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.